Phase
Condition
Colic
Treatment
Placebo
HMO
Parental reassurance and support
Clinical Study ID
Ages 2-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
Infants 2 weeks - 12 weeks of age at enrolment
Infants diagnosed with colic according to Rome IV criteria: Diagnostic criteria forresearch purposes (infant must meet all Rome IV criteria):
An infant who is less than 5 months of age (in the current clinical trial, onlyinfants 2 weeks to 8 weeks of age will be enrolled) when the symptoms start andstop
Recurrent and prolonged periods of infant crying, fussing, or irritabilityreported by caregivers that occur without obvious cause and cannot be preventedor resolved by caregivers
No evidence of infant failure to thrive, fever, or illness
Excessive crying/fussiness for 3 or more hours per day during 3 or more days inthe past 7 days as reported by parents to the clinician
Total 24-hour crying plus fussing is 3 hours or more when measured by at leastone prospectively kept 24-hour behavior diary. (The Structured Infant Cryingand Fussing Diary will be dispensed at the screening visit (V0), completed fortwo 24-hour periods at H0 (days -3 to -1), and returned at V1 to be used aspart of the diagnostic criteria for infantile colic.)
Term infants (≥ 37 weeks) generally healthy with normal birth weight (≥2.5kg) andsingleton born
Predominantly formula fed* (formula fed ≥ 80% of the time) for at least 7 daysbefore randomization and the choice of formula feeding has been made by the parentsbefore the beginning of the trial.
Infants who have been on the same formula for the past 5 days
Signed informed consent obtained for infant's and parents'/Legally AcceptableRepresentative (LAR) participation in the study
Parent/LAR of infant agrees not to enroll infant in another interventional clinicalresearch study while participating in this study
Parent of the infant/LAR is willing and able to fulfill the requirements of thestudy protocol
Parent of infant can be contacted throughout the study
- Predominantly formula feeding defined in the study means that the infant'spredominant source of nourishment is formula. Specifically, infants are fedwith formula for at least 80% of total milk feeds per day.
Exclusion
Exclusion criteria:
Presence of any congenital condition and/or previous or current illness/infectionand (or) medication use that could interfere with the main study outcomes.
Clinical evidence of chronic illness or gastrointestinal disorders, major medicalproblems (e.g. ill, immunocompromised, major developmental or genetic abnormality).
Known cow's milk protein allergy, lactose intolerance, or galactosaemia; includingpresence of any allergic manifestations.
Received any special formula (e.g. lactose-free, hydrolyzed protein) within 5 daysbefore randomization or switched formulas within 5 days before randomization.
Received any of the following products/medication within 5 days beforerandomization:
Antibiotics
Alginate
Prokinetics
Proton pump inhibitors
Simethicone
L. reuteri probiotic
Formula containing Human milk Oligosaccharides
Other infant(s) <6months of age living in the same household.
Current participation in another interventional clinical trial.
Study Design
Study Description
Connect with a study center
Ospedale Pediatrico Giovanni XXIII, Policlinico di Bari
Bari, 70126
ItalySite Not Available
ASST FBF Sacco
Milano,
ItalySite Not Available
AOUP Paolo Giaccone
Palermo,
ItalySite Not Available
Azienda Ospedaliero -Universitaria Pisana
Pisa,
ItalySite Not Available
Centro de Salud El Ranero
Murcia, 30009
SpainSite Not Available
Hospital Clínico Universitario de Santiago de Compostela
Santiago de Compostela, 15706
SpainSite Not Available
Unidad de Estudios e Investigación IHP
Sevilla, 41014
SpainSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.